<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Arq Bras Cir Dig</journal-id>
      <journal-id journal-id-type="iso-abbrev">Arq Bras Cir Dig</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cirurgia Digestiva : ABCD = Brazilian Archives of Digestive Surgery</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0102-6720</issn>
      <issn pub-type="epub">2317-6326</issn>
      <publisher>
        <publisher-name>Col&#xE9;gio Brasileiro de Cirurgia Digestiva</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26176256</article-id>
      <article-id pub-id-type="pmc">4737341</article-id>
      <article-id pub-id-type="doi">10.1590/S0102-67202015000200016</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter To The Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Signet-ring cell hilar cholangiocarcinoma: case report</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Colangiocarcinoma hilar com c&#xE9;lulas em anel de sinete: relato de
caso</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>CHEDID</surname>
            <given-names>Marcio F.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>LUCAS</surname>
            <given-names>Eduardo Terra</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>CERSKI</surname>
            <given-names>Carlos Thadeu S.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>LOPES</surname>
            <given-names>Maria Francisca T.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>AMARAL</surname>
            <given-names>Olavo B.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>CHEDID</surname>
            <given-names>Aljamir D.</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
        </contrib>
      </contrib-group>
      <aff id="aff01">Divis&#xE3;o de Cirurgia Geral e Oncol&#xF3;gica, Hospital Moinhos de Vento (Division
of General and Oncological Surgery, Moinhos de Vento Hospital), Porto Alegre, RS,
Brazil</aff>
      <author-notes>
        <corresp id="c01"><bold>Correspondence:</bold> Marcio F. Chedid E-mail:
<email>marciochedid@hotmail.com</email></corresp>
        <fn fn-type="conflict">
          <p>Conflicts of interest: none</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Apr-Jun</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Apr-Jun</season>
        <year>2015</year>
      </pub-date>
      <volume>28</volume>
      <issue>2</issue>
      <fpage>148</fpage>
      <lpage>149</lpage>
      <history>
        <date date-type="received">
          <day>27</day>
          <month>2</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>1</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Signet-ring cell (SRC) carcinomas are poorly-differentiated malignant tumors that may
affect the stomach and the colon, but very rarely occur in other digestive
organs<sup><xref rid="r01" ref-type="bibr">1</xref>, <xref rid="r03" ref-type="bibr">3</xref></sup>. Although SCR distal bile duct cholangiocarcinomas have
been very rarely reported<sup><xref rid="r02" ref-type="bibr">2</xref>, <xref rid="r04" ref-type="bibr">4</xref>, <xref rid="r07" ref-type="bibr">7</xref></sup>
we herein first report the occurrence of a SRC hilar cholangiocarcinoma.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 66-year-old caucasian woman was admitted with a 40-day history of fatigue, anorexia,
jaundice, itching and pale stools. She had undergone external percutaneous transhepatic
drainage and had been treated for cholangitis with antibiotics. The patient had no
palpable masses and her past medical history was unremarkable. Total bilirubin and liver
enzymes were mildly elevated, and CBC was normal. Abdominal computed tomography showed a
4.0 x 0.5 cm tumor on the confluence of the right and left hepatic bile ducts with
moderately dilated intrahepatic ducts. It also revealed a 2 cm tumor in the left kidney.
Additional workup was negative for metastases.</p>
      <p>Laparotomy was performed and revealed a hardened mass involving the common bile duct
from above the implantation of the cystic duct to the confluence of the right and left
hepatic ducts. Resection of the biliary tree was then carried out from the supraduodenal
portion of the common bile duct to the first 2 cm of the right and left hepatic ducts,
with en-bloc regional lymphadenectomy. A Roux-en-Y jejunal loop was taken to the hepatic
hilum and right, left and caudate bile ducts were sewn to a single jejunal loop.</p>
      <p>Macroscopic exam of the bile duct tumor revealed a 5.5x0.8cm surgical specimen that was
firm and scirrhous tumor located on the confluence of the right and left hepatic ducts
(Klatskin tumor). Bile duct confluence had a narrow lumen but no stones or mucin.
Gallbladder had no stones or wall thickening.</p>
      <p>Pathology report revealed a poorly differentiated SRC hilar cholangiocarcinoma (UICC
T4N0M0) with free proximal and distal margins and microscopically focally positive
circumferential margins (<xref ref-type="fig" rid="f01">Figure 1</xref>). Resected lymph
nodes had no metastases.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>Figure 1.</label>
        <caption>
          <p>Histological analysis: bile duct tumor with signetring cells (hematoxylin-eosin,
x200); histological examination of the tumor revealed solid and infiltrative
growth by pleomorphic round undifferentiated tumor cells with signet-ring
morphology</p>
        </caption>
        <graphic xlink:href="abcd-28-02-0148-g01"/>
      </fig>
      <p>The immunohistochemical profile confirmed the biliary origin of the SRC cancer (<xref ref-type="fig" rid="f02">Figure 2A</xref>, <xref ref-type="fig" rid="f02">2B</xref>
and <xref ref-type="fig" rid="f02">2C</xref>).</p>
      <fig id="f02" orientation="portrait" position="float">
        <label>Figure 2.</label>
        <caption>
          <p>Signet-ring cells stained for (A) CK19, (x 200); (B) CK07, (x 200); (C) CAM5.2, (x
200)</p>
        </caption>
        <graphic xlink:href="abcd-28-02-0148-g02"/>
      </fig>
      <p>As frozen section of the intraoperative incisional biopsy of the left kidney tumor was
suggestive of angiomyolipoma, nephrectomy was not performed at that time.</p>
      <p>Postoperative course was complicated by a biliary leak, and patient was discharged home
on 27<sup>th</sup> postoperative day. As the definitive pathology report for the kidney
tumor revealed a clear cell renal carcinoma; the patient underwent a left radical
nephrectomy after completely recovered from the first operation. Pathology report
confirmed the diagnosis of renal cell carcinoma with free margins. Postoperative course
was uneventful. Nevertheless, the patient died of local recurrence of SRC carcinoma 15
months after the first operation.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Three previous cases of primary biliary SRCC that have been reported in the
English-language literature, all consisting of distal bile duct SRCCs occurring in Asian
patients<sup><xref rid="r02" ref-type="bibr">2</xref>, <xref rid="r04" ref-type="bibr">4</xref>, <xref rid="r07" ref-type="bibr">7</xref></sup>. Two of those
patients underwent surgical resection of the primary tumor (pancreaticoduodenectomy).
None of the previous bile duct SRC carcinomas consisted of a hilar cholangiocarcinoma
(Klatskin tumor). Thus, to the best of our knowledge, this is the first report of a SRC
of a signet-ring hilar cholangiocarcinoma. This is a relevant fact, since hilar
cholangiocarcinomas carry a worse prognosis than distal bile duct cancers, being usually
more aggressive and less amenable to surgical resection. Additionally, surgical
treatment employed for hilar cholangiocarcinoma (bile duct resection with bilioenteric
anastomoses) is different to the one used for lower bile duct cancers
(pancreaticoduodenectomy).</p>
      <p>Although risk factors for cholangiocarcinoma include primary sclerosing cholangitis,
congenital biliary malformations, and parasitic liver disease, and hepatolithiasis, none
of those was present in the case herein reported. This is the first report the
occurrence of a SRC bile duct cancer in a Western patient, and this might be relevant
since cholangiocarcinomas in the East possess epidemiology and etiology that are diverse
to those bile duct cancers occurring in Western countries. A higher incidence of
cholangiocarcinoma in the East has been largely credited to colonization by liver
<italic>Opisthorchis viverrini</italic> and <italic>Clonorchis sinensis</italic>,
liver flukes that may induce inflammatory changes in the biliary tree and are endemic in
Asian countries.</p>
      <p>Although one could hypothesize that SCR hilar cholangiocarcinomas would arise from
gastric ectopic or metaplastic mucosa<sup><xref rid="r04" ref-type="bibr">4</xref></sup>, no evidence of gastric mucosa was found in the surgical specimen of the
case reported herein. It has also been demonstrated that bile duct epithelium may
undergo a sequence hyperplasia-metaplasia-dysplasia-carcinoma similarly to the one of
intestinal-type gastric adenocarcinomas. Nevertheless, no evidence for such sequence was
found in this case. In fact, biliary SRC carcinomas are poorly-differentiated aggressive
tumors that may arise de novo as it is thought to occur in SRC gastric carcinomas. As
happened in this case, most cholangiocarcinomas share expression of markers of
progenitor cells such as CK7 and CK19. Thus, it is suggested that cholangiocarcinomas
are monoclonal tumors that may arise from hepatobiliary pluripotent stem cells<sup><xref rid="r09" ref-type="bibr">9</xref></sup>.</p>
      <p>Another uncommon finding in the case presented here is the association between
cholangiocarcinoma and clear cell renal cancer<sup><xref rid="r06" ref-type="bibr">6</xref>, <xref rid="r08" ref-type="bibr">8</xref></sup>. Although bile duct
obstruction could have been attributed to the occurrence of a biliary metastasis from
renal cell carcinoma<sup><xref rid="r10" ref-type="bibr">10</xref></sup>, immunohistochemical
analysis confirmed the biliary epithelial origin in this case (positivity for CK19,
CK07, CAM 5.2 and AE1+AE3)<sup><xref rid="r05" ref-type="bibr">5</xref></sup>. Renal cell clear
carcinomas do not usually stain for all these markers. Although Levy <italic>et
al.</italic>
<sup><xref rid="r06" ref-type="bibr">6</xref></sup> described the occurrence of simultaneous
intrahepatic cholangiocarcinoma and a left kidney cancer in a patient on long-term use
of methotrexate, there was no previous chronic use of any medications in this case<sup><xref rid="r08" ref-type="bibr">8</xref></sup>. Thus, the association of a renal cell carcinoma
with a SRC Klatskin tumor is likely to be fortuitous in this case.</p>
      <p>Cholangiocarcinoma is an aggressive malignant tumor and it is possible that the presence
of signet-ring cells could confer additional aggressiveness to this tumor. Further
studies will be necessary to confirm or refute this hypothesis.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p>Financial source: none</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gardner</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Matthews</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Ciano PS: A signet-ring cell carcinoma of the ampulla of
Vater.</article-title>
          <source>Arch Pathol Lab Med</source>
          <year>1990</year>
          <volume>114</volume>
          <fpage>1071</fpage>
          <lpage>1072</lpage>
          <pub-id pub-id-type="pmid">2171451</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hiraki</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yakushiji</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hashiguchil</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Signet ring cell carcinoma of the lower bile duct with rapid growth:
report of a case</article-title>
          <source>Hepatogastroenterology</source>
          <year>2007</year>
          <volume>54</volume>
          <fpage>1922</fpage>
          <lpage>1924</lpage>
          <pub-id pub-id-type="pmid">18251129</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Karabulut</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Yildirim</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Abaci</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ilgici</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Ozyilkan O: Signet-ring cell carcinoma of the gallbladder: a case
report.</article-title>
          <source>Adv Ther</source>
          <year>2008</year>
          <volume>25</volume>
          <fpage>520</fpage>
          <lpage>523</lpage>
          <pub-id pub-id-type="pmid">18461291</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>EY</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Signet ring cell carcinoma of the extrahepaticbile
duct</article-title>
          <source>Gut Liver</source>
          <year>2010</year>
          <volume>4</volume>
          <fpage>402</fpage>
          <lpage>406</lpage>
          <pub-id pub-id-type="pmid">20981222</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Expression of mucins and cytokeratins in primary carcinomas of the
digestive system.</article-title>
          <source>Mod Pathol</source>
          <year>2003</year>
          <volume>16</volume>
          <fpage>403</fpage>
          <lpage>410</lpage>
          <pub-id pub-id-type="pmid">12748245</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Levy</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Nisar</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Karanjia</surname>
              <given-names>ND</given-names>
            </name>
          </person-group>
          <article-title>Cholangiocarcinoma, renal cell carcinoma and parathyroid adenoma found
synchronously in a patient on long-term methotrexate</article-title>
          <source>HPB (Oxford)</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>151</fpage>
          <lpage>153</lpage>
          <pub-id pub-id-type="pmid">18333265</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ogata</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Kimura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hatsuse</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Poorly differentiated adenocarcinoma with signet-ring cell carcinoma
of the extrahepatic bile duct in a 42-year-old Japanese female: a case
report</article-title>
          <source>Acta Med Okayama</source>
          <year>2010</year>
          <volume>64</volume>
          <fpage>63</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">20200586</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pachar</surname>
              <given-names>JV</given-names>
            </name>
            <name>
              <surname>Crooks</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ermocilla</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Hepatocholangiocarcinoma associated with renal clear cell
carcinoma.</article-title>
          <source>Rev Med Panama</source>
          <year>1987</year>
          <volume>12</volume>
          <fpage>37</fpage>
          <lpage>40</lpage>
          <pub-id pub-id-type="pmid">3035626</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roskams</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Liver stem cells and their implication in hepatocellular and
cholangiocarcinoma</article-title>
          <source>Oncogene</source>
          <year>2006</year>
          <volume>25</volume>
          <fpage>3818</fpage>
          <lpage>3822</lpage>
          <pub-id pub-id-type="pmid">16799623</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ueda</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Taka</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kusano</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Metastatic biliary polypoid thrombus from renal cell carcinoma: report
of a case.</article-title>
          <source>Surg Today</source>
          <year>2002</year>
          <volume>32</volume>
          <fpage>458</fpage>
          <lpage>461</lpage>
          <pub-id pub-id-type="pmid">12061702</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
